Back to Search
Start Over
Supplementary Table 2 from High BCR–ABL/GUSIS Levels at Diagnosis of Chronic Phase CML Are Associated with Unfavorable Responses to Standard-Dose Imatinib
- Publication Year :
- 2023
- Publisher :
- American Association for Cancer Research (AACR), 2023.
-
Abstract
- Supplementary Table 2. Outcome comparison in patients recruited to the IRIS, German CML IV and SCREEN studies
Details
- Database :
- OpenAIRE
- Accession number :
- edsair.doi.dedup.....12c9cf50cc01614176bfe84fab65afa3